ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0415

Prevalence and Risk Factors of Low Bone Mineral Density in Children with Juvenile Idiopathic Arthritis

narendra bagri, Sushain Kalsotra, vandana jain, Manisha Jana, Maroof Ahmed Khan, Yashdeep Gupta and Sumit Kumar Das, All India Institute of Medical Sciences, New Delhi, Delhi, India

Meeting: ACR Convergence 2024

Keywords: Bone density, Bone Resorption, Dual energy x-ray absorptiometry (DEXA), Juvenile idiopathic arthritis, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatological disease in children less than 16 years of age. Various factors have been suggested to negatively influence JIA patients’ bone mineral density (BMD). Decreased BMD has a long-term implication in such patients, making them more prone to fractures later in life.

To determine the prevalence and risk factors associated with low bone mineral density (BMD) in children with Juvenile Idiopathic Arthritis (JIA).

Methods: This cross-sectional study was conducted at the Pediatric Rheumatology Clinic, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi.

All children diagnosed with JIA as per ILAR criteria were screened for eligibility. Children aged 5-18 years with JIA and disease more than one year were enrolled; those with bisphosphonate intake, bone damage due to other causes like infection, trauma, and JIA with overlap syndrome were excluded. Demographic details, clinical assessments, and laboratory investigations, including serum calcium, CRP, RF/anti-CCP, vitamin D3, and intact PTH, were recorded in a predesigned performa. Disease activity and functional disability were assessed using the clinical Juvenile Arthritis Disease Activity Score-10 (cJADAS-10) and Steinbrocker. BMD was measured using DXA at the lumbar spine and left femoral neck. Low BMD was defined as a Z-score ≤ – 2 SD at either of the two sites. Analysis was done using StataCorp. 2021. Stata statistical software: Release 18. Multivariate logistic regression was done to identify factors associated with low BMD.

Results: 101 children with 68.3% (69/101) males with a mean age of 154.6 months with a median disease duration of 48 months and a median delay in initiation of therapy of 14 months. Enthesitis-related arthritis (54.5%) was the most common subtype, followed by systemic JIA (36%). The demographic and laboratory characteristics are depicted in Table 1.

The prevalence of low BMD was 55.4% (56/101). Significant risk factors for low BMD included higher cJADAS scores, lower height Z-scores, longer delay in initiation of therapy, and higher levels of intact PTH. Univariate analysis identified BMI, disease duration, systemic steroid use, and CRP levels as potential risk factors. Multivariate analysis confirmed that lower height Z-scores and higher cJADAS scores were independently associated with low BMD. Table 2 depicts the results of the regression analysis. The area under the ROC curve was 0.79. A nomogram to predict the probability of low BMD was developed and is represented in Figure 1.

Conclusion: Significant children with JIA have low BMD. Addressing the identified risk factors, i.e. disease activity and delay in initiation of therapy, might help prevent long-term skeletal complications.

Supporting image 1

Table 1. Demographic details, Variables, and Laboratory parameters of the study population

Supporting image 2

Table 2. Logistic regression analysis for factors associated with low BMD

Supporting image 3

Figure 1. Nomogram predicting probability of low BMD in children with JIA


Disclosures: n. bagri: None; S. Kalsotra: None; v. jain: None; M. Jana: None; M. Khan: None; Y. Gupta: None; S. Das: None.

To cite this abstract in AMA style:

bagri n, Kalsotra S, jain v, Jana M, Khan M, Gupta Y, Das S. Prevalence and Risk Factors of Low Bone Mineral Density in Children with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-low-bone-mineral-density-in-children-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-low-bone-mineral-density-in-children-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology